P02.136. A randomized controlled trial for the use of qigong in the treatment of pre and mild essential hypertension by Park, J et al.
POSTER PRESENTATION Open Access
P02.136. A randomized controlled trial for the use
of qigong in the treatment of pre and mild
essential hypertension
J Park
1*, S Hong
2, T Park
3, Y Liu
1, J Kim
1, T Kim
1, A Kim
1, S Jung
1, H Park
1, S Choi
1
From International Research Congress on Integrative Medicine and Health 2012
Portland, Oregon, USA. 15-18 May 2012
Purpose
Hypertension is a risk factor for cardiovascular disease,
and the prevalence of hypertension tends to increase
with age. Current treatments for hypertension have side
effects and poor adherence. Qigong has been studied as
an alternative therapy for hypertension; however, the
types of qigong used in those studies were diverse, and
there have not been many well-designed randomized
controlled trials. Our objective is to evaluate the effects
of qigong on blood pressure, health status and hormone
levels for pre- or mild hypertension.
Methods
Forty subjects with pre- or mild hypertension were
randomized to either the qigong exercise group or the
non-treated group. Participants in the qigong group con-
ducted qigong exercises 5 times per week for 8 weeks,
and participants in the non-treated group maintained
their current lifestyle, including diet and exercise. The
use of antihypertensive medication was not permitted.
The primary endpoint was a change in patient blood
pressure. Secondary endpoints were patient health status
(as measured by the MYMOP2 questionnaires) and
changes in hormone levels.
Results
Of the 40 participants that were randomized, 35 com-
pleted the study. Systolic and diastolic blood pressures
were significantly decreased after qigong treatment com-
pare to baseline only in the qigong group (p<.001 in SBP,
p<.0001 in DBP). In the non-treated group, there was no
significant difference in blood pressure. Change of blood
pressure between the qigong and the non-treated group
was significant (p<.01 in SBP and DBP). The score of
MYMOP2 showed a more significant decrease in the
qigong group than the non-treated group (p=.035). Any
differences in the hormones renin, angiotensin, cortisol,
or norepinephrine were not significant between the two
groups.
Conclusion
Qigong appears safe and has a positive effect on blood
pressure and health status in pre and mild hypertension
patients. Further long-term studies with a larger number
of subjects are warranted.
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